Tuesday, July 16, 2019

ResMed Raises $500M In Private Placement Debt

San Diego-based ResMed, which develops medical devices used to treat sleep apnea, COPD and other chronic diseases, has raised $500M in a private placement debt financing, the company said on Monday afternoon. According to the publicly traded firm (NYSE: RMD) the funding came in the form of $250,000,000 principal amount 3.24% senior notes due July 10, 2026

The story you have requested is only available to paid members of the socalTECH.com web site. Premium articles are restricted to paid members only. Please login in order to access this members-only content, or become a member.